Medical Costs and Healthcare Utilization among Cancer Decedents in the Last Year of Life in 2009
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study was to evaluate the cancer care cost during the last year of life of patients in Korea. Materials and Methods We studied the breakdown of spending on the components of cancer care. Cancer dece- dents in 2009 were identified from the Korean Central Cancer Registry and linked with the Korean National Health Insurance Claims Database. The final number of patients included in the study was 70,558. Results In 2009, the average cancer care cost during the last year of life was US $15,720. Patients under age 20 spent US $53,890 while those 70 or over spent US $11,801. Those with leukemia incurred the highest costs (US $43,219) while bladder cancer patients spent the least (US $13,155). General costs, drugs other than analgesics, and test fees were relatively high (29.7%, 23.8%, and 20.7% of total medical costs, respectively). Analgesic drugs, reha- bilitation, and psychotherapy were still relatively low (4.3%, 0.7%, and 0.1%, respectively). Among the results of multiple regression analysis, few were notable. Age was found to be negatively related to cancer care costs while income level was positively associated. Those classified under distant Surveillance, Epidemiology, and End Results stages of cancer and higher comorbidity level also incurred higher cancer care costs. Conclusion Average cancer care costs varied significantly by patient characteristics. However, the study results suggest an underutilization of support services likely due to lack of alternative accommodations for terminal cancer patients. Further examination of utilization patterns of healthcare resources will help provide tailored evidence for policymakers in efforts to reduce the burdens of cancer care.
Abstract
Purpose The purpose of this study was to evaluate the cancer care cost during the last year of life of patients in Korea. Materials and Methods We studied the breakdown of spending on the components of cancer care. Cancer dece- dents in 2009 were identified from the Korean Central Cancer Registry and linked with the Korean National Health Insurance Claims Database. The final number of patients included in the study was 70,558. Results In 2009, the average cancer care cost during the last year of life was US $15,720. Patients under age 20 spent US $53,890 while those 70 or over spent US $11,801. Those with leukemia incurred the highest costs (US $43,219) while bladder cancer patients spent the least (US $13,155). General costs, drugs other than analgesics, and test fees were relatively high (29.7%, 23.8%, and 20.7% of total medical costs, respectively). Analgesic drugs, reha- bilitation, and psychotherapy were still relatively low (4.3%, 0.7%, and 0.1%, respectively). Among the results of multiple regression analysis, few were notable. Age was found to be negatively related to cancer care costs while income level was positively associated. Those classified under distant Surveillance, Epidemiology, and End Results stages of cancer and higher comorbidity level also incurred higher cancer care costs. Conclusion Average cancer care costs varied significantly by patient characteristics. However, the study results suggest an underutilization of support services likely due to lack of alternative accommodations for terminal cancer patients. Further examination of utilization patterns of healthcare resources will help provide tailored evidence for policymakers in efforts to reduce the burdens of cancer care.
참고문헌 (25)
- Yabroff KR, "Costs of cancer care in the USA : adescriptive review", Nat Clin Pract Oncol, 4, pp.643~656 (2007)
- Mariotto AB, "Projections of the cost of cancer care in the United States : 2010-2020", J Natl Cancer Inst, 103, pp.117~128 (2011)
- Statistics Korea, "Annual report on the cause of death statistics" (2007), Korea National Statistical Office
- National Cancer Center, Ministry of Health and Welfare, "Cancer facts and figures 2013 in the Republic of Korea" (2013), National Cancer Center
- Yabroff KR, "Economic burden of cancer in the United States : estimates, projections, and future research", Cancer Epidemiol Biomarkers Prev, 20, pp.2006~2014 (2011)
- Chastek B, "Healthcare costs for patients with cancer at the end of life", J Oncol Pract, 8, pp.75~80 (2012)
- Hogan C, "Medicare beneficiaries’costs of care in the last year of life", Health Aff(Millwood), 20, pp.188~195 (2001)
- 이지전, "암환자에서 암발생부위와 생존기간에 따른 사망전 1년간의 의료비용", 예방의학회지, 38(1), pp.9~15 (2005), 대한예방의학회
- 주수영, "교육수준별 2004년 암 사망자의 사망 전 1년간 의료이용의 차이와 정책적 함의", 예방의학회지, 40(1), pp.36~44 (2007), 대한예방의학회
- 최귀선, "호스피스케어와 전통적 의료서비스 이용간의 사망전 의료비용 비교", 보건행정학회지, 15(2), pp.1~15 (2005), 한국보건행정학회
- Yoon TH, "In equalities in medical care utilization by South Korean cancer patients according to income : a retrospective cohort study", Int J Health Serv, 41, pp.51~66 (2011)
- Dinan MA, "Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006", JAMA, 303, pp.1625~1631 (2010)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009", Cancer Research and Treatment, 44(1), pp.11~24 (2012), 대한암학회
- Kim SY, "Disparities in utilization of high-volume hospitals for cancer surgery: results of a Korean population-based study", Ann Surg Oncol, 17, pp.2806~2815 (2010)
- "Review: summary staging" (2014)[URL]
- Brown ML, "The burden of illness of cancer : economic costand quality of life", Annu Rev Public Health, 22, pp.91~113 (2001)
- Yabroff KR, "Projections of the costs associated with colorectal cancer care in the United States, 2000-2020", Health Econ, 17, pp.947~959 (2008)
- Athas WF, "Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery", J Natl Cancer Inst, 92, pp.269~271 (2000)
- 김성경, "우리나라 암 환자의 개인부담 의료비용", 대한내과학회지, 70(1), pp.61~68 (2006), 대한내과학회
- Keam B, "Aggressiveness of cancer-care near the end-of-life in Korea", Jpn J Clin Oncol, 38, pp.381~386 (2008)
- Fawzy FI, "Psychosocial interventions for patients with cancer : what works and what doesn’t", Eur J Cancer, 35, pp.1559~1564 (1999)
- Yoshioka H, "Rehabilitation for the terminal cancer patient", Am J Phys Med Rehabil, 73, pp.199~206 (1994)
- Sharp L, "The financial impact of a cancer diagnosis" (2010), Irish Cancer Society
- Yang Y, "Contribution of imaging to cancer care costs", J Nucl Med, 52(Suppl 2), pp.86~92 (2011)
- Brown ML, "Estimating health care costs related to cancer treatment from SEER-Medicare data", Med Care, 40(8 Suppl), pp.104~117 (2002)